Sergei Shevtsov

2.0k citations
11 papers · 1.6k · 1 hit paper · h-index 8

Impact in

Papers in

    • DNA and Nucleic Acid Chemistry 2
    • Molecular Biology Techniques and Applications 2
    • DNA Repair Mechanisms 1
    • Plant biochemistry and biosynthesis 1
    • Lipoproteins and Cardiovascular Health 3

Sergei Shevtsov

11 papers receiving 1.5k citations

Sergei Shevtsov's Hit Papers

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate 2006 · 908 citations
9080+6+13Years since publication250500750

Peers

Sergei Shevtsov
Comparison fields: 5 of 108
  • Hematology 316
  • Cardiology and Cardiovascular Medicine 413
  • Pharmacology 135
  • Genetics 146
  • Rheumatology 165
Replace Kevin J. Duffy with:
Kevin J. Duffy United States
John K. Leighton United States
Edvardas Kaminskas United States
Xia Bai China
R. Osieka Germany
Martha Hokom United States
Glen S. Germain United States
Johannes Noé Switzerland
Th.J.C. van Berkel Netherlands
Connie L. Erickson‐Miller United States
Sergei Shevtsov relative to Kevin J. Duffy United States Kevin J. Duffy's profile →
Citations per field
00.5×8.3×
Kevin J. Duffy · 1×
Citations per year

Countries citing papers authored by Sergei Shevtsov

Since Specialization
Citations

This map shows the geographic impact of Sergei Shevtsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Shevtsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Shevtsov more than expected).

Fields of papers citing papers by Sergei Shevtsov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergei Shevtsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Shevtsov. The network helps show where Sergei Shevtsov may publish in the future.

Co-authors

The 25 scholars most cited alongside Sergei Shevtsov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sergei Shevtsov Line = papers co-authored together Sergei Shevtsov links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Hit paper breakdown →
2006908
2 2001273
3 2006113
4 2002100
5 202169
6 200360
7 199131
8 199811
9 20167
10 19987
11 19986

About Sergei Shevtsov

Sergei Shevtsov is a scholar working on Molecular Biology, Surgery, Cancer Research, Cardiology and Cardiovascular Medicine and Rheumatology, having authored 11 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (3 papers), Lipoproteins and Cardiovascular Health (3 papers), DNA and Nucleic Acid Chemistry (2 papers), Molecular Biology Techniques and Applications (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), DNA Repair Mechanisms (1 paper) and Plant biochemistry and biosynthesis (1 paper). The work is most often cited by research in Hematology (316 citations), Cardiology and Cardiovascular Medicine (413 citations), Pharmacology (135 citations), Genetics (146 citations) and Rheumatology (165 citations). Sergei Shevtsov has collaborated with scholars based in United States, Russia and Japan. Frequent co-authors include Evgeniy V. Petrotchenko, Lars C. Pedersen, Masahiko Negishi, Risto Kerkelä, Thomas Force, Richard D. Patten, Robert Salomon, Jean‐Bernard Durand, Fred J. Clubb and Brian Walters. Their work appears in journals such as Molecular Genetics and Metabolism, Nature Medicine, Nucleus, Human Mutation and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact